Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Redhill Biopharma Ltd RDHL

Healthcare
RedHill Biopharma Ltd is an Israel-based specialty biopharmaceutical company primarily focused on gastrointestinal and infectious diseases. RedHill promotes the gastrointestinal drugs such as, Talicia for the treatment of Helicobacter pylori (H. pylori) infection, and Aemcolo, for the treatment of travelers’ diarrhea. RedHill’s clinical late-stage development programs include: :info: RHB-204... see more

Recent & Breaking News (NDAQ:RDHL)

Publication of Data from Severe COVID-19 Patients Shows Substantial Benefit to Patients Treated with RedHill's Opaganib Compared to Matched Case-Control Group

GlobeNewswire June 24, 2020

Virtual Conference for Life Sciences Companies Broadcast Live June 25, 2020

GlobeNewswire June 23, 2020

RedHill Biopharma to Present at Virtual Life Sciences Investor Forum on June 25

GlobeNewswire June 22, 2020

RedHill Biopharma Expands Opaganib COVID-19 Phase 2/3 Study with Clinical Trial Applications in Italy and UK

GlobeNewswire June 18, 2020

RedHill Biopharma to Present at Virtual Life Sciences Investor Forum on June 25

GlobeNewswire June 18, 2020

RedHill Biopharma Submits COVID-19 Clinical Trial Application for Phase 2/3 Study with Opaganib

GlobeNewswire June 10, 2020

RedHill Biopharma to Provide Update on its COVID-19 and other Development Programs at MedInvest Virtual Infectious Diseases and Immunology Conference

GlobeNewswire June 8, 2020

RedHill Biopharma to Present at BIO Digital

GlobeNewswire June 1, 2020

RedHill Biopharma to Present at Jefferies Virtual Healthcare Conference

GlobeNewswire May 28, 2020

RedHill Biopharma Provides Q1/2020 Financial Results and Recent Highlights Including Initial Movantik® Revenues

GlobeNewswire May 27, 2020

RedHill Biopharma to Host First Quarter Financial Results Conference Call on May 27, 2020

GlobeNewswire May 20, 2020

RedHill Biopharma to Present at the UBS Virtual Global Healthcare Conference

GlobeNewswire May 11, 2020

RedHill Biopharma Receives FDA Approval for COVID-19 Clinical Study with Opaganib in the U.S.

GlobeNewswire May 8, 2020

RedHill Biopharma Announces Publication of Talicia® Pivotal Phase 3 Study Results in Annals of Internal Medicine

GlobeNewswire May 5, 2020

RedHill Biopharma Strengthens Coverage for Talicia® with Preferred Brand Position on Prime Therapeutics NetResults(TM) National Formulary

GlobeNewswire April 28, 2020

Six COVID-19 Patients Treated with RedHill's Opaganib Under Compassionate Use Show Objective Clinical Improvement

GlobeNewswire April 27, 2020

RedHill Biopharma Announces Agreement with NIAID to Evaluate RHB-107 Against COVID-19

GlobeNewswire April 20, 2020

IND for COVID-19 with Opaganib Submitted to the FDA by RedHill Biopharma

Thomson Reuters ONE April 17, 2020

Additional Update on COVID-19 Compassionate Use with Opaganib in Israel Provided by RedHill Biopharma

GlobeNewswire April 17, 2020

RedHill Biopharma Provides Initial Update from its Opaganib COVID-19 Compassionate Use Program in Israel

GlobeNewswire April 13, 2020